Hypoxia-inducible factor-1 and oncogenic signalling

被引:163
|
作者
Bárdos, JI [1 ]
Athcroft, M [1 ]
机构
[1] Inst Canc Res, Ctr Canc Therapeut, Cell Growth Regulat & Angiogenesis Lab, Sutton SM2 5NG, Surrey, England
关键词
D O I
10.1002/bies.20002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An understanding of underlying mechanisms Involved in the activation of HIF-1 in response to both hypoxic stress and oncogenic signals has important implications for how these processes may become deregulated in human dancer. Changes in microenvironmental stimuli such as hypoxia and growth factors in combination With genetic lesions such as loss or inactivation of p53, PTEN or pVHL or oncogenic activation, can all lead to increased HIF-1 activity This provides cancer cells With a distinct ad Vantage for survival and proliferation, resulting in their ability to form vascular tumours, which are aggressive and metastatic. Accordingly, upregulation of HIF-1alpha, a key component of HIF-1, correlates with a poor treatment outcome Using conventional therapies. A Variety of mechanisms exist that regulate expression of HIF-lalpha. In recent years, it has become clear that an extensive network of signalling cascades converge on HIF-1alpha to regulate the transcriptional response. A better understanding of this regulation may provide 6 basis for the development of new cancer therapies. BioEssays 26:M 269, 2004. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 50 条
  • [31] Copper Regulation of Hypoxia-Inducible Factor-1 Activity
    Feng, Wenke
    Ye, Fei
    Xue, Wanli
    Zhou, Zhanxiang
    Kang, Y. James
    MOLECULAR PHARMACOLOGY, 2009, 75 (01) : 174 - 182
  • [32] Skeletal muscle hypoxia-inducible factor-1 and exercise
    Lindholm, Malene E.
    Rundqvist, Helene
    EXPERIMENTAL PHYSIOLOGY, 2016, 101 (01) : 28 - 32
  • [33] Hypoxia-Inducible Factor-1α and Autoimmune Lupus, Arthritis
    Yang, Zu-Cheng
    Liu, Yi
    INFLAMMATION, 2016, 39 (03) : 1268 - 1273
  • [34] Honokiol inhibits hypoxia-inducible factor-1 pathway
    Lan, Keng-Li
    Lan, Keng-Hsin
    Sheu, Meei-Ling
    Chen, Ming-Yuan
    Shih, Yi-Sheng
    Hsu, Fu-Chih
    Wang, Hong-Ming
    Liu, Ren-Shyan
    Yen, Sang-Hue
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2011, 87 (06) : 579 - 590
  • [35] Dexamethasone impairs hypoxia-inducible factor-1 function
    Wagner, A. E.
    Huck, G.
    Stiehl, D. P.
    Jelkmann, W.
    Hellwig-Buergel, T.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (02) : 336 - 340
  • [36] Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
    Li, Y.
    Ye, D.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (07) : 782 - 796
  • [37] Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors
    Robey, IF
    Lien, AD
    Welsh, SJ
    Baggett, BK
    Gillies, RJ
    NEOPLASIA, 2005, 7 (04): : 324 - 330
  • [38] Hypoxia-inducible factor-1α regulation of myeloid cells
    C. L. Stothers
    L. Luan
    B. A. Fensterheim
    J. K. Bohannon
    Journal of Molecular Medicine, 2018, 96 : 1293 - 1306
  • [39] Synthesis of Neolamellarin A, an Inhibitor of Hypoxia-inducible Factor-1
    Arafeh, Khaled M.
    Ullah, Nisar
    NATURAL PRODUCT COMMUNICATIONS, 2009, 4 (07) : 925 - 926
  • [40] Hypoxia-Inducible Factor-1 in Multiple Myeloma Progression
    Ria, Roberto
    Reale, Antonia
    Berardi, Simona
    Piccoli, Claudia
    Di Pietro, Giulia
    Basile, Antonio
    Capitanio, Nazareno
    Vacca, Angelo
    BLOOD, 2009, 114 (22) : 720 - 720